267 related articles for article (PubMed ID: 15227623)
1. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.
Springer SA; Pesanti E; Hodges J; Macura T; Doros G; Altice FL
Clin Infect Dis; 2004 Jun; 38(12):1754-60. PubMed ID: 15227623
[TBL] [Abstract][Full Text] [Related]
2. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment regimen outcomes among HIV-infected prisoners.
Springer SA; Friedland GH; Doros G; Pesanti E; Altice FL
HIV Clin Trials; 2007; 8(4):205-12. PubMed ID: 17720660
[TBL] [Abstract][Full Text] [Related]
4. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
5. Predictors of reincarceration and disease progression among released HIV-infected inmates.
Baillargeon J; Giordano TP; Harzke AJ; Spaulding AC; Wu ZH; Grady JJ; Baillargeon G; Paar DP
AIDS Patient Care STDS; 2010 Jun; 24(6):389-94. PubMed ID: 20565323
[TBL] [Abstract][Full Text] [Related]
6. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
Stephenson BL; Wohl DA; Golin CE; Tien HC; Stewart P; Kaplan AH
Public Health Rep; 2005; 120(1):84-8. PubMed ID: 15736336
[TBL] [Abstract][Full Text] [Related]
7. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.
Meyer JP; Cepeda J; Springer SA; Wu J; Trestman RL; Altice FL
Lancet HIV; 2014 Nov; 1(2):e77-e84. PubMed ID: 25473651
[TBL] [Abstract][Full Text] [Related]
8. Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study.
Resino S; M Bellón J; Gurbindo D; Tomás Ramos J; Antonio León J; Jose Mellado M; Angeles Muñoz-Fernández M
Clin Infect Dis; 2003 Nov; 37(9):1216-25. PubMed ID: 14557967
[TBL] [Abstract][Full Text] [Related]
9. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
10. An audit of HIV care in English prisons.
Chan SY; Marsh K; Lau R; Pakianathan M; Hughes G
Int J STD AIDS; 2015 Jun; 26(7):504-8. PubMed ID: 25080291
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
[TBL] [Abstract][Full Text] [Related]
12. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
13. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
14. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
15. HIV outcomes at a Canadian remand centre.
Subramanian Y; Khan MN; Berger S; Foisy M; Singh A; Woods D; Pyne D; Ahmed R
Int J Prison Health; 2016 Sep; 12(3):145-56. PubMed ID: 27548017
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.
Duro M; Rebelo I; Barreira S; Sarmento-Castro R; Medeiros R; Almeida C
Int J STD AIDS; 2015 Oct; 26(11):796-802. PubMed ID: 25281540
[TBL] [Abstract][Full Text] [Related]
17. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
20. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
